PUBLIC CONSULTATION ANNOUNCEMENT

Guidelines for Registration of Importers of Medicines

The National Medicines Regulatory Authority (NMRA) hereby announces the commencement of the public consultation on the Draft Guidelines for Registration of Importers of Medicines

All relevant stakeholders, including pharmaceutical manufacturers, medicine importers, Marketing Authorization Holders (MAHs), healthcare professionals,academic experts, industry representatives, and other interested parties, are invited to review the draft guideline and submit their comments and suggestions.

Stakeholders are requested to provide clear, evidence-based and, where applicable,appropriately referenced comments to support the review and finalization of the guideline.

Submission of Comments

All comments, suggestions, and technical inputs should be submitted by email to: pa28@nmra.gov.lk

Deadline for submission of comments: 10 September 2026

Stakeholders are encouraged to clearly identify the relevant section or provision of the draft guideline to which their comments relate.

All submissions received during the consultation period will be reviewed and considered by the NMRA in finalizing the Guidelines for Registration of Importers of Medicines

The NMRA appreciates the participation and valuable contributions of all stakeholders in strengthening the regulatory framework governing the importation of medicines in Sri Lanka.

See link: Guidelines for Registration of Importers of Medicines